| Product Name | NebuSelect™ Recombinant Mouse TMEM106B, hFc-tag |
|---|---|
| Catalog Number | NBL-242045 |
| Alias/Synonyms | TMEM106B; Transmembrane protein 106B;Tmem106b |
| Appearance | see COA |
| Molecule Weight | Pro119-Gln275 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Q80X71 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-242045-100ug | 100ug | Inquire | Inquire | |
| NBL-242045-1mg | 1mg | Inquire | Inquire | |
| NBL-242045-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse TMEM106B, hFc-tag
Catalog#:
NBL-242045
Description:
NebuSelect™ Recombinant Mouse TMEM106B, hFc-tag(Cat#NBL-242045) is expressed in HEK293 with hFc tag at the C-Terminus.It contains Pro119-Gln275.
Species:
Mouse
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 44.8 kDa. Due to glycosylation, the protein migrates to 65-68 kDa based on Bis-Tris PAGE result.
Target Name:
TMEM106B; Transmembrane protein 106B;Tmem106b
Target Information:
TMEM106B is a well-recognised risk factor for FTD caused by GRN mutation. Elegant experiments have suggested that increased risk for FTD is due to elevated levels of TMEM106B (Nicholson et al, 2013; Gallagher et al, 2017). Therefore, recent work has explored the therapeutic potential of reducing TMEM106B levels, with initial results looking encouraging, as crossing a Grn-deficient mouse to a Tmem106b knockout showed a rescue in FTD-related behavioural defects and specific aspects of lysosome dysfunction (Klein et al, 2017).
Amino Acid Sequence:
Pro119-Gln275
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.